Explore how JAX scientists are decoding the genetic and molecular factors underlying biological function and human disease.
Research Labs A-ZFind JAX mouse models, platforms and services to enable scientific discoveries, inform decision-making and de-risk preclinical drug development.
Models & ServicesGet the training you need to succeed in today’s scientific and clinical settings with our courses, mentored research and educational resources.
Education & Learning
Here at JAX, we are bridging the gap between mouse and human data to drive biological discovery and accelerate translation to the clinic. With the latest equipment, methodologies and best-in-class core services, our highly collaborative and diverse research teams are overcoming long-standing challenges in a variety of research and disease areas.
Developing the most sophisticated models and applications, we are committed to providing you with the tools that propel science.
Education runs deep at JAX, and our many in-person, virtual and online education programs reach thousands of learners each year across the globe. Whether you’re a high school student or postdoctoral associate exploring careers in science, or a practicing clinician or established scientist, you’ll find something new to learn at JAX.
Teaching the Genome Generation has expanded to the Memphis Shelby County School District, offering high school teachers and students enhanced genetics …
View More
Mitchell (Mitch) Kennedy joins JAX as executive vice president, JAX and president, JAX® Mice, Clinical and Research Services (JMCRS).
View More
Christine Beck led a team that explored mouse genome, and revealed details across 20 diverse inbred strains that will be critical for informing…
View More
Participants from Nigeria, Tunisia, Egypt, Mali, Senegal, DR Congo, Ghana and South Africa came to Bar Harbor to learn from talks at the…
View More
“The Jackson Laboratory has a unique combination of critical components to realize the long-awaited potential of genetics for predicting, treating and modifying the course of disease.”
— President & CEO Lon Cardon, Ph.D., FMedSci